The Food and Drug Administration approved a generic version of mifepristone, the drug most commonly used to terminate pregnancy during a medication-induced abortion.

The drug is the second version of generic mifepristone to be marketed.

It comes just days after Health and Human Services Secretary Robert F. Kennedy, Jr., said the FDA would review its existing approvals of mifepristone.

In to state attorneys general, Secretary Kennedy and FDA commissioner Dr. Marty Makary said the agency would revisit the Risk Evaluation and Mitigation Strategy for mifepristone.

The letter points to a from the Ethics and Public Policy Center, a conservative think tank with ties to the Heritage Foundation and Project 2025, that claimed to show that 11% of women taking the drug experienced "serious adverse

See Full Page